
2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Highlights on mNSCLC: Will the Efficacy of T-DXd in HER2+ Disease Add HER2 Mutation to the List of Essential NSCLC Biomarkers? OS With Bevacizumab + Erlotinib in EGFR+ NSCLC - Does It Change the Role of Osimertinib in 1L Therapy?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Michael Shafique
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Michael Shafique
0 views
September 25, 2020
Comments 0
Login to view comments.
Click here to Login
Lung